Home » Topics » Disease categories and therapies » Hematologic

Hematologic
RSS

Lovenox superiority established in ESSENCE trial

Aug. 21, 1997

Fibrinogen antagonists from Yamanouchi

Aug. 20, 1997

Stanford announces three studies on leg ischemia treatments

Aug. 20, 1997

Glaxo Wellcome discloses a new series of thrombin inhibitors

Aug. 18, 1997

Arginine mimetics from Boehringer Mannheim

Aug. 13, 1997

Normiflo launched in U.S.

Aug. 12, 1997

Dietary changes may pose threat to patients on oral anticoagulants

Aug. 8, 1997

Texas Biotechnology and SmithKline Beecham form marketing alliance for Novastan

Aug. 7, 1997

Berlex reports novel anticoagulants

Aug. 6, 1997

Barr Laboratories halts shipment of warfarin educational materials

Aug. 6, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 4, 2026.
University of Western Australia patents 5-HT2A/B modulators
BioWorld Science
University of Western Australia has identified new lysergic acid diethylamide (LSD) analogues acting as 5-HT2A and 5-HT2B modulators reported to be useful for the...
Alceptor Therapeutics discovers new α2B-adrenoceptor agonists
BioWorld Science
Alceptor Therapeutics Inc. has patented new pyrazol-5-amine α2B-adrenoceptor agonists reported to be useful for the treatment of pain and hypertension.
EQ-504 is AhR agonist for ulcerative colitis, related disorders
BioWorld Science
Activating the aryl hydrocarbon receptor (AhR) in immune cells enhances anti-inflammatory pathways and limits pathogenic immune responses. Equillium Inc. has...
Quintuple GLP-1–GIP–PPAR agonist for obesity and diabetes control
BioWorld
A new molecule combines the action of two incretins, GLP-1 and GIP, hormones that regulate glucose and appetite, with lanifibranor, a triple agonist of peroxisome...